ReviewJournal of neural transmission (Vienna, Austria : 1996)2025
Dysphagia and oropharyngeal bradykinesia in Parkinson's disease.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Botulinum Toxin Injections for Drooling Improve Dysphagia in Patients with Parkinson's Disease.Toxins · 2026Article
- Effects of focal low energy extracorporeal shock wave treatment on reduction of sialorrhea in Parkinson's disease.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dysphagia is a manifestation of swallowing dysfunction frequently observed in Parkinson's disease (PD). It can lead to serious clinical consequences when the patient experience aspiration or chest infections. Even in less severe cases, dysphagia significantly affects patients' quality of life. Understanding the pathophysiology underlying PD-related dysphagia is important for proper classification and for objectifying swallowing abnormalities with clinical evaluation. This review explores the mechanisms of swallowing, the various aspect of swallowing abnormalities, and their impact on the quality of life of PD patients-especially in relation to impaired responses to levodopa-and discusses suggested therapeutic approaches. In our opinion, true dysphagia in PD is less common than often believed. Swallowing difficulties may reflect oropharyngeal and/or lingual bradykinesia. Hypokinesia, a hallmark motor symptom of PD, may affect swallowing reflex and result in prolonged pharyngeal reflex times due to slow, sequential muscle movements. Symptoms such ad difficulty swallowing, food retention, sensation of food in the esophagus, and the need to drink liquids to aid bolus transit are more indicative of bradykinesia than dysphagia. Therefore, swallowing abnormalities should be carefully assessed and properly classified, with tailored pharmacological treatment and dietary adjustments for each individual case.
Indexed as
Identifiers
41117926What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.